Pivotal Data Demonstrating Efficacy of Plenadren® (Hydrocortisone, Modified ... Sacramento Bee 16, 2012 -- /PRNewswire/ -- ViroPharma Incorporated (NASDAQ: VPHM) today announced that data from the pivotal study for their orphan drug Plenadren® (hydrocortisone, modified release tablet) were published in the Journal of Clinical Endocrinology and ... |
